Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

BACKGROUND: In the current study, we pooled imaging data in newly diagnosed glioblastoma (GBM) patients from international multicenter clinical trials, single institution databases, and multicenter clinical trial consortiums to identify the relationship between postoperative residual enhancing tumor...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Ellingson, Benjamin M, Abrey, Lauren E, Nelson, Sarah J, Kaufmann, Timothy J, Garcia, Josep, Chinot, Olivier, Saran, Frank, Nishikawa, Ryo, Henriksson, Roger, Mason, Warren P, Wick, Wolfgang, Butowski, Nicholas, Ligon, Keith L, Gerstner, Elizabeth R, Colman, Howard, de Groot, John, Chang, Susan, Mellinghoff, Ingo, Young, Robert J, Alexander, Brian M, Colen, Rivka, Taylor, Jennie W, Arrillaga-Romany, Isabel, Mehta, Arnav, Huang, Raymond Y, Pope, Whitney B, Reardon, David, Batchelor, Tracy, Prados, Michael, Galanis, Evanthia, Wen, Patrick Y, Cloughesy, Timothy F
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Neuroimaging
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071654/
https://ncbi.nlm.nih.gov/pubmed/29660006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy053
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia